|
|
||||||||
Department of Biomolecular Science, Faculty of Science, Toho University, Funabashi, Chiba, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
was detected when human monocyte-derived macrophages (MDM)
3 were cocultured with apoptotic polymorphonuclear cells for 10 h.
Because phosphatidylserine (PS) exposure on apoptotic cells is believed to be involved in the uptake of apoptotic cells by macrophages (3), we have examined the response of macrophages after phagocytosis using annexin V-positive/propidium iodide (PI)-positive cells as apoptotic cells (4). Although such apoptotic cells are at a late stage of apoptosis, there was no release of cytoplasmic proteins, as assessed as to lactate dehydrogenase, indicating that secondary necrosis had not occurred. In addition, it was indicated that the recognition was mediated through PS, because the uptake was suppressed by phospho-L-serine (PLS). Unexpectedly, a large amount of IL-8 was produced when the response of macrophages was examined upon phagocytosis of apoptotic cells. Although the production of IL-8 was always significant irrespective of the stage of apoptosis, the more advanced the stage of apoptosis was the greater the amount of IL-8 produced by macrophages in the phagocytosis of the cells. As our subsequent study revealed, however, when human serum was included during phagocytosis by human macrophages, the level of IL-8 was decreased, whereas the levels of anti-inflammatory cytokines TGF-
and IL-10 were increased, although the phagocytosis efficiency did not change (5). Furthermore, the anti-inflammatory cytokine production by macrophages also increased as the stage of apoptosis advanced. Of note was that the suppressive effect of human serum was not observed with necrotic cells. Therefore, this effect of human serum seems to be specific to apoptotic cells. Overall, phagocytosis of apoptotic cells by macrophages appears to be associated with the production of anti-inflammatory cytokines in vitro.
Although we do not discount these results concerning the production of anti-inflammatory cytokines during coculture with apoptotic cells, we considered whether such production might be physiologically irrelevant. For example, the body has one hundred million apoptotic neutrophils every day. The phagocytosis of apoptotic neutrophils would produce large amounts of IL-10 and TGF-
in the blood. Because apoptotic cells are always phagocytosed not only in the blood but also in other places, high levels of IL-10 and TGF-
should be produced throughout our body. Consequently, unknown mechanisms must operate in vivo to prevent such production. Besides, apoptotic cells are hardly detected in normal tissues. Taken together, we hypothesized that upon receipt of an apoptotic signal, cells at a very early stage of apoptosis are quickly phagocytosed without any adverse effects. To test this hypothesis, in this study, we shorten the induction time for apoptosis to determine by flow cytometry and confocal laser microscopy at what stage apoptotic cells are phagocytosed by macrophages. We also examine the macrophage response upon phagocytosis of apoptotic cells.
| Materials and Methods |
|---|
|
|
|---|
An IL-2-dependent CTL line, CTLL-2 cells, was washed with PBS (20 mM PBS, pH 7.4, containing 14 mM Na2HPO4 and 6 mM KH2PO4) by centrifugation at 1000 rpm for 10 min at 4°C, followed by incubation in an IL-2-free RPMI 1640 medium containing 10% FCS (Life Technologies, Gaithersburg, MD) for 012 h at 37°C at a cell density of 5 x 105 cells/ml. A murine leukemic cell line, P388 cells, was adjusted to the cell density of 106 cells/ml in the culture medium, followed by the addition of 1 mg/ml of etoposide (WAKO, Osaka, Japan) to a final concentration of 1 µg/ml, and then the cells were incubated for 5 h at 37°C.
Preparation of cells and phagocytosis
THP-1 cells were maintained in RPMI 1640 medium containing 10% FCS (Life Technologies). The cells were washed with PBS three times, followed by incubation in 10% FCS-RPMI and 160 nM PMA for 72 h at 37°C at a cell density of 5 x 105 cells/ml. CTLL-2 cells were maintained in RPMI 1640 medium containing 10% FCS, 5 x 10-5 M 2-ME and 100 U/ml of recombinant human IL-2 (kindly provided by Takeda Pharmaceutical, Osaka, Japan). To induce apoptosis, CTLL-2 cells were washed with PBS three times, followed by incubation in an IL-2-free medium for various times at 37°C at a cell density of 5 x 105 cells/ml. PMA-treated THP-1 cells were washed with PBS three times, followed by the addition of apoptotic CTLL-2 cells and incubation for 1, 2, or 3 h at 37°C in RPMI 1640 medium containing 10% FCS. As a positive control for cytokine production, PMA-treated THP-1 cells were stimulated with 0.1 µg/ml LPS (Escherichia coli O55B5; Difco, Detroit, MI) for 3 h. Human MDM were obtained by culturing plastic-adherent human PBMC in RPMI 1640 medium containing 10% FCS and 1000 U/ml of human M-CSF derived from human urine (Denka, Tokyo, Japan) for 3 days, replacing half of the medium with fresh medium, and then culturing them for an additional 4 days. Mouse thioglycolate broth-induced peritoneal exudate cells (PEC), Kupffer cells, and alveolar macrophages were obtained according to the standard methods previously described (6, 7). Irrespective of the kind of macrophages used, phagocytosis assay was performed in RPMI 1640 medium containing 10% FCS.
Flow cytometric analysis
The cell size and PS exposure were analyzed by flow cytometry using a FACScan and Lysys software (BD Biosciences, San Jose, CA). PS exposure was estimated by FITC- or Cy3-conjugated Annexin V staining. FITC- and Cy3-Annexin V were purchased from Bender MedSystems (Vienna, Austria) and Biovision (Mountain View, CA), respectively. PMA-treated THP-1 cells were cocultured with apoptotic CTLL-2 cells for 3 h at 37°C in RPMI 1640 medium containing 10% FCS. The cells were then washed with PBS three times and placed on ice. Adherent cells were recovered by gentle flushing with prechilled PBS and tapping of the bottom of the plate.
Confocal microscopy
CTLL-2 cells and P388 cells were stained with PKH26 dye (red fluorescence) (Sigma-Aldrich, St. Louis, MO), followed by culturing with macrophages for 3 h at 37°C in RPMI 1640 medium containing 10% FCS in a slide chamber. The cells were washed, and adherent cells were recovered. The cells were then stained with FITC-conjugated mouse mAb to human HLA-ABC class I (Serotec, Oxford, U.K.) for 15 min at 4°C. The cells were examined by confocal microscopy using a FluoView system (Olympus, Tokyo, Japan). Phagocytosis was confirmed by means of z-axis scanning every time. The phagocytic cells are defined as cells containing at least one PKH26-positive cell. The phagocytosis, as a percentage, was determined by dividing the number of phagocytic cells by the number of macrophages (adherent cells) (at least 200).
MitoTracker staining
To measure the membrane potential of mitochondria, a cationic lipophilic fluorochrome, chloromethyl X-rosamine (CMXRos) (8), was purchased from Molecular Probes (Eugene, OR). CTLL-2 cells were incubated at 37°C for 15 min in the presence of CMXRos (0.1 mM), followed by immediate analysis of fluorochrome incorporation with a flow cytometer. In control experiments, cells were labeled in the presence of uncoupling agent carbonyl cyanide mClCCP (100 µM; Sigma-Aldrich). CMXRos fluorescence was recorded in FL3.
Assay for caspase-3-like protease activity
Caspase-3-like protease activity was measured according to the method previously described (9). Briefly, cells were washed with PBS, and then lysed with a lysing buffer (PBS containing 0.2% Nonidet P-40, 50 µg/ml leupeptin, 5 mM EDTA, 1 mM PMSF, and 10 µg/ml phosphoramidon) for 30 min on ice. The cell lysates were centrifuged, and the supernatants were incubated with a reaction buffer (40 mM Tris-HCl, pH 7.4, 1.6 mM DTT, 4% sucrose, 0.1 mM acetyl-Asp-Glu-Val-Asp-
-(4-methyl-coumaryl-7-amide) (Ac-DEVD-MCA; Peptide Institute, Osaka, Japan), and 1% DMSO) for 30 min at 37°C, followed by the addition of an equal volume of a stop buffer (11.65 g/l sodium monochloroacetate and 4.08 g/l sodium acetate, pH 4.3). After incubation for 30 min on ice and centrifugation, the 7-amino-4-methylcoumarin liberated was measured by spectrofluorometry (excitation at 370 nm, emission at 460 nm). According to the manufacturers information, not only caspase-3 but also caspases-7 and -8 can be measured with the substrate. The enzyme activity was expressed as picomole of 7-amino-4-methylcoumarin per minute per milligram of protein.
Nuclear condensation assay
Cells were fixed with 2% glutaraldehyde for 24 h at 4°C, followed by staining with 0.17 mM Hoechst 33342 for 1 min on ice and subsequent staining with 77 µg/ml PI for 10 min on ice. The cells were then observed under a fluorescence microscope.
Inhibitors
PLS, phospho-L-tyrosine (PLT), RGDS (Arg-Gly-Asp-Ser), and RGES (Arg-Gly-Glu-Ser) were purchased from Sigma-Aldrich, and diluted in RPMI 1640 to 100 mM. Dextran sulfate (DXS) was diluted in RPMI 1640 to 10 mg/ml. Macrophages were pretreated with these inhibitors for 30 min at 37°C. Apoptotic cells were then added, followed by incubation for 3 h at 37°C, after which phagocytosis and cytokine production were evaluated.
RT-PCR
Total RNA was isolated from a coculture, and RT-PCR was performed as previously described (10). For semiquantitation, cDNA was serially diluted, followed by RT-PCR with
2-microglobulin (
2m) primers and PAGE. After measurement of the intensity of each band, the results were expressed as a percentage of
2m. The detection limit was 1% of
2m. The primers (5' primer and 3' primer), annealing temperatures, concentrations of MgCl2, and predicted sizes were previously described. In this study, the annealing temperature for the TGF-
primers was changed to 56°C. The PCR products were digested with appropriate restriction enzymes to confirm the specificity.
Measurement of cytokines
After coculturing, the cells were centrifuged and the supernatants were harvested. Samples were stored at -80°C until the assay. The human IL-8 level was determined by means of a specific ELISA, for which the reagents were provided by Dr. K. Matsushima (University of Tokyo School of Medicine, Tokyo, Japan), as previously described (11), except that polyclonal rabbit anti-human IL-8 Abs and anti-human IL-8 mAb (WS4) were used. The detection limit for IL-8 was
10 pg/ml. The concentration of macrophage-inflammatory protein (MIP)-2 was determined by means of a specific ELISA with the combination of polyclonal rabbit anti-murine MIP-2 Ab and recombinant MIP-2, for which the reagents were provided by Dr. K. Matsushima, as previously described (12). The detection limit for MIP-2 was
50 pg/ml. The concentrations of IL-10 and TGF-
were determined by means of specific ELISAs (BioSource International, Camarillo, CA). The detection limits for IL-10 and TGF-
were 11 pg/ml and 8 pg/ml, respectively. For TGF-
determination, samples were not extracted with acid ethanol so that a latent inactive precursor abundant in serum was not detected. Moreover, the values for given amounts of an active form of human TGF-
supplied by a manufacturer in the presence of human serum were almost identical with those in the absence of human serum (e.g., 40.0 vs 39.7 pg/ml), indicating that only an active form of TGF-
was detected with this assay.
Statistics
The significance of the data was evaluated by means of Students t test or one-factor ANOVA followed by Fisher PLSD test. The p value <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
Growth factor-dependent cells are known to become apoptotic when cultured in the absence of a growth factor. In this study, we used IL-2-dependent CTLL-2 cells as growth factor-dependent cells. As shown in Fig. 1A (left and middle panels), CTLL-2 cells exhibited a decrease in cell size after 9-h culture in the absence of IL-2. In addition, the exposure of PS was also detected with FITC-Annexin V after 9-h culture (10.2% positive), and the extent of exposure became more significant as the cells were incubated for longer times (for instance 87.5% positive after 12-h culture). The cells were not stained by PI even after 12-h culture. DNA ladder formation and nuclear condensation, conversely, were detected only after 12-h culture and 24-h culture, respectively. Moreover, these apoptotic cells did not release cytoplasmic enzymes, as assessed as lactate dehydrogenase activity.
|
|
Although the data are not shown, we observed the phagocytosis of FITC-Annexin V-negative very early apoptotic P388 cells treated with etoposide for 5 h, suggesting that such phagocytosis is not restricted to CTLL-2 cells.
We then characterized such an early stage of apoptosis as to various criteria including an increase in cell surface PS, lowering of the membrane potential of mitochondria, and the activation of caspase-3-like protease. We first analyzed cell surface PS with Cy3-Annexin V, because Cy3-Annexin V is more sensitive than FITC-Annexin V. As shown in Fig. 3, a very small increase in cell surface PS was detected with a flow cytometer. When 3-h apoptotic CTLL-2 cells were analyzed, cell surface PS was the same as found in normal CTLL-2 cells, measured by mean fluorescence intensity (MFI) for normal unstained cells, 17 ± 1.7; MFI for normal cells stained with Cy3-Annexin V, 29 ± 1.1; MFI for unstained 3-h apoptotic cells, 17 ± 1.8; MFI for 3-h apoptotic cells stained with Cy3-Annexin V, 30 ± 0.7. When we analyzed very early apoptotic P388 cells after treatment with etoposide for 5 h, essentially the same results were obtained (MFI for control unstained cells, 17 ± 0.4; MFI for control cells stained with Cy3-Annexin V, 25 ± 1.0; MFI for etoposide-treated unstained cells, 18 ± 2.2; MFI for etoposide-treated cells stained with Cy3-Annexin V, 35 ± 0.8). Then, we analyzed the membrane potential of mitochondria of very early apoptotic cells by staining with MitoTracker. The MFI decreased from 4351 for live cells to 2540 for the very early apoptotic cells, indicating lowering of the membrane potential of mitochondria (Fig. 4A). The lowering of the membrane potential of mitochondria was also detected in 3-h apoptotic CTLL-2 cells (data not shown). Finally, we examined kinetics of the activation of caspase-3-like protease. As shown in Fig. 4B, a slight but significant activation was observed at 3 and 6 h, whereas the activation peaked at 12 h. Taken together, only the increase in cell surface PS among examined appears to differentiate between 3-h apoptotic CTLL-2 cells and 4-h apoptotic ones, although the differences were very small.
|
|
We then examined the cytokine production upon coculturing of macrophages with apoptotic cells at various stages. First, the mRNA levels of various cytokines in each coculture were determined by semiquantitative RT-PCR (Fig. 5A). We examined proinflammatory cytokines IL-1
, IL-1
, IL-6. IL-8, and TNF-
, and anti-inflammatory cytokines IL-1 receptor antagonist, IL-10, and TGF-
. Among those tested, only the expression of IL-1
, IL-8, IL-10, and TGF-
mRNA was increased. It was commonly observed irrespective of the cytokine that the expression level increased as the stage of apoptotic cells advanced. In addition, no expression of cytokine mRNAs except for that of IL-8 was detected in macrophages upon coculturing with very early apoptotic cells after 4-h culture in the absence of IL-2. Of note was that even IL-8 mRNA was expressed at a remarkably low level. IL-8 protein level was then measured by a specific ELISA (Fig. 5B). IL-8 protein began to be detected in a coculture with very early apoptotic cells after 4-h culture in the absence of IL-2 and it increased with the stages of apoptosis. In our previous work, IL-8 protein was detected as early as the 1-h coculture and reached a plateau after 3-h coculture (5). Consequently IL-8 protein should have also been produced in a coculture with CTLL-2 cells after 3-h culture in the absence of IL-2, although the level was undetectable, i.e., <10 pg/ml (Fig. 5B).
|
, and suppression of proinflammatory IL-8 production (Fig. 6). When IgG was added at a final concentration of 5 mg/ml instead of human serum, it also led to an increase in the production of IL-10 (<11 vs 43.5 ± 16.8 pg/ml) and TGF-
(11.7 ± 2.6 pg/ml vs 146.5 ± 32.4 pg/ml), and suppression of IL-8 production (0.53 ± 0.01 ng/ml vs 0.21 ± 0.01 ng/ml). Such changes were similar in the case of macrophages that phagocytosed FITC-Annexin V-high positive cells, but the cytokine production by macrophages phagocytosing very early apoptotic cells was significantly low, irrespective of the presence of human serum. The same was true for etoposide-treated very early apoptotic P388 cells (data not shown).
|
We then examined by what mechanism very early apoptotic cells were phagocytosed by macrophages. First we added inhibitors known to inhibit the phagocytosis of apoptotic cells, namely RGDS and PLS, the former blocking phagocytosis via the vitronectin receptor and the latter blocking phagocytosis through PS (Fig. 7, A and B). PLS showed greater suppression than RGDS when the IL-8 production of macrophages on coculturing was examined (Fig. 7A). Macrophages produced undetectable levels of IL-8 (i.e., <10 pg/ml) without coculturing with apoptotic cells, and these inhibitors did not affect the response. PLS also showed greater suppression than RGDS when phagocytosis was examined by flow cytometry (Fig. 7B) and confocal microscopy (Table I), indicating that phagocytosis itself was significantly inhibited by PLS.
|
|
| Discussion |
|---|
|
|
|---|
This study also demonstrated that such phagocytosis is not accompanied by the production of either anti-inflammatory or proinflammatory cytokines, leading to "silent cleanup" (Figs. 5 and 6). Because cells with apoptotic features are hardly detected in normal tissues, such phagocytosis of very early apoptotic cells without the production of cytokines should occur throughout the body, thereby maintaining an inflammation-free status under healthy conditions.
When the cell populations containing very early apoptotic P388 cells were cocultured with PMA-treated THP-1 cells, somewhat higher levels of IL-8 were produced in comparison with other combinations of apoptotic cells and macrophages (Table I), raising the possibility that silent cleanup may be restricted to particular cell types. Of note, however, was that production of IL-8 after a coculture with the cell populations containing very early apoptotic P388 cells was approximately one-eighth the production of P388 cells treated with etoposide for 28 h (this study and Ref.14) (see below).
Although the very early apoptotic cells were Cy3-Annexin V low-positive, they showed neither a decrease in cell size (Fig. 1A), DNA ladder formation, chromatin condensation, nor ability to stain with PI. Such a small increase in surface PS, however, was not observed in 3-h apoptotic CTLL-2 cells. Although these data were reproducible, we really need more sensitive assay methods for detection of surface PS and are currently trying to develop it. It has been recognized that apoptotic signals induce lowering of the membrane potential of mitochondria leading to the activation of caspase (15, 16, 17, 18, 19). Conversely, PS exposure is controlled by caspases (20) other than caspase-3 (21). Morphological changes, which are key features of apoptosis, are also controlled by caspase-3 (21). To characterize the very early apoptotic cells, we also analyzed the membrane potential of mitochondria and caspase-3-like protease activity. As a result, we found lowering of the membrane potential of mitochondria as well as the activation of caspase-3-like protease in 3-h apoptotic CTLL-2 cells. This demonstrated differences between live cells and very early apoptotic cells, clearly indicating that such very early apoptotic cells have already started the apoptotic process.
We then examined the cytokine production by macrophages on coculturing with apoptotic cells at various stages (Fig. 5A). Of note was that no expression of cytokines except for IL-8 was detected in macrophages upon coculturing with the cell populations containing very early apoptotic cells. The expression level of IL-8 mRNA after a coculture with the cell populations containing the very early apoptotic cells was approximately one-hundredth of that with apoptotic cells after 12-h culture in the absence of IL-2 (FITC-Annexin V high-positive, PI-negative). When the IL-8 protein level was measured by a specific ELISA, the production after a coculture with the cell populations containing the very early apoptotic cells was approximately one-eighth of the production with apoptotic cells after 12-h culture in the absence of IL-2 (FITC-Annexin V high-positive, PI-negative). Although it is widely accepted that an anti-inflammatory response is associated with the phagocytosis of apoptotic cells, neither IL-10 nor TGF-
was detected at the protein or mRNA level upon coculture with the cell populations containing the very early apoptotic cells. When macrophages phagocytosed the cell populations containing the very early apoptotic cells in the presence of human serum or IgG, we obtained a similar result with FITC-Annexin V high-positive apoptotic cells, in which the production of anti-inflammatory IL-10 and TGF-
was increased, whereas the proinflammatory IL-8 production was suppressed (5), the levels of cytokines detected being much lower than those with FITC-Annexin V high-positive apoptotic cells. IgG was thus principally responsible for the change in cytokine production described in this study, being compatible with our previous work that identified IgG as a main active component in human serum for such a change in cytokine production in association with phagocytosis of apoptotic cells (5).
We then examined how macrophages discriminate very early apoptotic cells from live cells by using inhibitors such as PLS and RGDS (Fig. 6, A and B). Because PLS suppressed IL-8 production as well as phagocytosis significantly, we hypothesized that macrophages recognized the acidic materials that are not expressed on the cell surface of live cells. By using various combinations of Cy3-Annexin V low-positive very early apoptotic cells and macrophages, we then examined the effects of PLT, as an analog of PLS, and DXS, as a negatively charged substance, on IL-8 or MIP-2 production as well as phagocytosis. Whichever reagents and combinations of apoptotic cells and macrophages were used, PLS showed the greatest suppression. These results may indicate that the macrophages recognized very early apoptotic cells through cell surface PS, for which the increase was only detected with Cy3-Annexin V (Fig. 3). Although it is possible that a change in the localization of PS on very early apoptotic cells is specifically recognized by macrophages, we could not detect such a change even with Cy3-Annexin V. Because it was recently reported that the phagocytosis of apoptotic cells promotes programmed cell death in Caenorhabditis elegans (22, 23), there is another possibility that recognition of very early apoptotic cells by macrophages dramatically hastens PS exposure. Although we examined possible changes in PS exposure during coculture, we could not detect any. On the other hand, an acidic substance may be concerned with the mechanism of phagocytosis through scavenger receptors, because DXS inhibited phagocytosis by Kupffer cells significantly. Further research is indeed necessary to elucidate the mechanism of phagocytosis of very early apoptotic cells.
Several mechanisms for the phagocytosis of apoptotic cells have been reported so far, as follows: 1) changes in the carbohydrate structure on the cell membrane are recognized by a lectin-like molecule (24), 2) unknown molecules on apoptotic cells are recognized by receptors on macrophages (vitronectin receptor and CD36) through thrombospondin (25, 26, 27, 28, 29), 3) PS exposed on the cell surface is recognized by receptors including scavenger receptor LOX-1 and SR-BI (30, 31, 32), and 4) apoptotic cells are recognized by CD14, SR-AI/II, and ABC class 1 molecules on macrophages (33, 34, 35).
Among the mechanisms previously described, interaction between PS and receptors has been extensively analyzed and supported by many researchers. In the normal cell membrane, most phospholipids are distributed asymmetrically between the double layers, which are thought to be regulated by multiple enzymatic actions to control the transfer of phospholipids (36, 37). Generally, over 90% of PS is localized in the internal layer of the cell membrane. Apoptosis induces changes in these enzymatic activities to abolish the asymmetry of the phospholipid distribution and to expose PS on the cell surface (38, 39, 40). Although it was found that exposure of PS is controlled by caspases, it has not yet been clarified how enzymatic activities are altered to expose PS during the progress of apoptosis. In contrast, a PS receptor on macrophages was reported in 2000 (30). In addition, Ogden et al. (41) newly discovered another mechanism for phagocytosis through CD91, in which C1q and mannose-binding protein in serum bind to normal cells as well as blebs and calreticulin with altered localization on apoptotic cells, causing phagocytosis. Determination of whether or not such mechanisms are involved in the recognition of Cy3-Annexin V low-positive very early apoptotic cells by macrophages awaits further investigation.
In summary, upon triggering of apoptosis, very early apoptotic cells appear to be silently cleaned up by macrophages as if nothing also happens, contributing to maintenance of homeostasis. Conversely, when the timing for appropriate phagocytosis is retarded for some reason, inflammation may occur through unbalanced production of proinflammatory cytokines under some conditions, such as the absence of human serum in the vicinity of macrophages.
| Footnotes |
|---|
2 Address correspondence and reprints requests to Dr. Yoshiro Kobayashi, Laboratory of Molecular Immunology, Department of Biomolecular Science, Faculty of Science, Toho University, 2-2-1, Miyama, Funabashi, Chiba 274-8510, Japan. E-mail address: yoshiro{at}biomol.sci.toho-u.ac.jp ![]()
3 Abbreviations used in this paper: MDM, monocyte-derived macrophages; PS, phosphatidylserine;
2m,
2-microglobulin; PI, propidium iodide; PLS, phospho-L-serine; CTLL, CTL line; PEC, peritoneal exudate cells; MIP, macrophage-inflammatory protein; CMXRos, chloromethyl X-rosamine; PLT, phospho-L-tyrosine; RGDS, Arg-Gly-Asp-Ser; RGES, Arg-Gly-Glu-Ser; MFI, mean fluorescence intensity; DXS, dextran sulfate. ![]()
Received for publication July 25, 2002. Accepted for publication July 24, 2003.
| References |
|---|
|
|
|---|
, PGE2, and PAF. J. Clin. Invest. 101:890.[Medline]
This article has been cited by other articles:
![]() |
B. Vollmar and M. D. Menger The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair Physiol Rev, October 1, 2009; 89(4): 1269 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maret, C. Ruffie, S. Letuve, A. Phelep, O. Thibaudeau, J. Marchal, M. Pretolani, and A. Druilhe A Role for Bid in Eosinophil Apoptosis and in Allergic Airway Reaction J. Immunol., May 1, 2009; 182(9): 5740 - 5747. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanmun, E. Witasp, S. Jitkaew, Y. Y. Tyurina, V. E. Kagan, A. Ahlin, J. Palmblad, and B. Fadeel Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease Am J Physiol Cell Physiol, January 1, 2009; 297(3): C621 - C631. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shibata, K. Nagata, and Y. Kobayashi Cutting Edge: A Critical Role of Nitrogen Oxide in Preventing Inflammation upon Apoptotic Cell Clearance J. Immunol., September 15, 2007; 179(6): 3407 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-P. Erwig and P. M. Henson Immunological Consequences of Apoptotic Cell Phagocytosis Am. J. Pathol., July 1, 2007; 171(1): 2 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Elmore Apoptosis: A Review of Programmed Cell Death Toxicol Pathol, June 1, 2007; 35(4): 495 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saijo, K. Nagata, J. Masuda, I. Matsumoto, and Y. Kobayashi Discrimination of Early and Late Apoptotic Cells by NBD-phosphatidylserine-labelling and Time-lapse Observation of Phagocytosis of Apoptotic Cells by Macrophages J. Biochem., March 1, 2007; 141(3): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Freire-de-Lima, Y. Q. Xiao, S. J. Gardai, D. L. Bratton, W. P. Schiemann, and P. M. Henson Apoptotic Cells, through Transforming Growth Factor-beta, Coordinately Induce Anti-inflammatory and Suppress Pro-inflammatory Eicosanoid and NO Synthesis in Murine Macrophages J. Biol. Chem., December 15, 2006; 281(50): 38376 - 38384. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shibata, K. Nagata, and Y. Kobayashi A suppressive role of nitric oxide in MIP-2 production by macrophages upon coculturing with apoptotic cells J. Leukoc. Biol., October 1, 2006; 80(4): 744 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Hwang, Z. Yu, D. C. Palmer, and N. P. Restifo The In vivo Expansion Rate of Properly Stimulated Transferred CD8+ T Cells Exceeds That of an Aggressively Growing Mouse Tumor Cancer Res., January 15, 2006; 66(2): 1132 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Sawatzky, D. A. Willoughby, P. R. Colville-Nash, and A. G. Rossi The Involvement of the Apoptosis-Modulating Proteins ERK 1/2, Bcl-xL and Bax in the Resolution of Acute Inflammation in Vivo Am. J. Pathol., January 1, 2006; 168(1): 33 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Michaels, H.-K. Kang, A. Kaliyaperumal, E. Satyaraj, Y. Shi, and S. K. Datta A Defect in Deletion of Nucleosome-Specific Autoimmune T Cells in Lupus-Prone Thymus: Role of Thymic Dendritic Cells J. Immunol., November 1, 2005; 175(9): 5857 - 5865. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Falasca, V. Iadevaia, F. Ciccosanti, G. Melino, A. Serafino, and M. Piacentini Transglutaminase Type II Is a Key Element in the Regulation of the Anti-Inflammatory Response Elicited by Apoptotic Cell Engulfment J. Immunol., June 1, 2005; 174(11): 7330 - 7340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Devitt, K. G. Parker, C. A. Ogden, C. Oldreive, M. F. Clay, L. A. Melville, C. O. Bellamy, A. Lacy-Hulbert, S. C. Gangloff, S. M. Goyert, et al. Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice J. Cell Biol., December 20, 2004; 167(6): 1161 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, K. Kurosaka, and Y. Kobayashi Immature dendritic cells reduce proinflammatory cytokine production by a coculture of macrophages and apoptotic cells in a cell-to-cell contact-dependent manner J. Leukoc. Biol., May 1, 2004; 75(5): 865 - 873. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |